posted on 2018-02-15, 10:26authored byZ. Vali, A. Mistry, W. B. Nicolson, G. Chu, X. Li, A. J. Sandilands, R. Somani, R. Chelliah, D. Chin, R. Pathmanathan, P. Stafford, G. A . Ng
Introduction: Since their introduction to standard clinical practice, implantable cardioverter defibrillators (ICD) have been shown in a number of clinical trials to improve survival. We review the changes seen in the numbers and demographics of patients receiving ICD or CRT-D implants at one large tertiary cardiology centre (Glenfield Hospital) with a catchment population of approximately 2 million.
History
Citation
EP-Europace, 2017, 19(suppl_1), pg. i26,
Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Cardiovascular Sciences
Source
Heart Rhythm Congress 2017
Version
AM (Accepted Manuscript)
Published in
EP-Europace
Publisher
Oxford University Press (OUP) for European Society of Cardiology (ESC), European Heart Rhythm Association
The file associated with this record is under embargo until 12 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.